CSBR revenue rises 8.8% to $15.2 million
Revenue rose 8.8% year over year to $15.2 million. Oncology services margin improved to 51%, adjusted EBITDA was $671,000 and net loss narrowed to $426,000.
Story updates
08:50:48 PM UTC
SquawkNews
Revenue grew 9% year-over-year to $15.2 million, with gross margin rising to 50% and adjusted EBITDA positive for the fifth consecutive quarter. Data licensing revenue exceeded all of last year in a single quarter, and the company ended with $4.4 million in cash and no debt.Based on Champions Oncol…
08:55:34 PM UTC
SquawkNews
CSBR: Q1 revenue up 9% year-over-year, gross margin at 50%, and data revenue surged past last year's total
2 million, with oncology services margin improving to 51% and adjusted EBITDA reaching $671,000. Original document: Champions Oncology, Inc. [CSBR] SEC 8-K Current R…